Combining metaphase cytogenetics with single nucleotide polymorphism arrays can improve the diagnostic yield and identify prognosis more precisely in myelodysplastic syndromes

BACKGROUND: Myelodysplastic syndromes (MDS) encompass a group of heterogeneous haematopoietic stem cell malignancies characterised by ineffective haematopoiesis, cytological aberrations, and a propensity for progression to acute myeloid leukaemia. Diagnosis and disease prognostic stratification are...

Descripción completa

Detalles Bibliográficos
Autores principales: Qin, Yao, Zhang, Hang, Feng, Lin, Wei, Haichen, Wu, Yuling, Jiang, Chaoran, Xu, Zhihong, Zhu, Huanling, Liu, Ting
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Hematology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9518301/
https://www.ncbi.nlm.nih.gov/pubmed/36148999
http://dx.doi.org/10.1080/07853890.2022.2125173

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9518301/
https://www.ncbi.nlm.nih.gov/pubmed/36148999
http://dx.doi.org/10.1080/07853890.2022.2125173

Ejemplares similares